InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: dndodd post# 60395

Wednesday, 10/18/2017 1:26:26 PM

Wednesday, October 18, 2017 1:26:26 PM

Post# of 140475
Selling like hotcakes in Europe! Apparently, Europeans don't like hotcakes.

ALF-X received its CE Mark in December 2011. According to this, no sales in Europe in 2012, 2013, 2014, 2015...

http://whitediamondresearch.com/research/transenterix-has-shady-management-and-impractical-surgical-bots/

I don't know who White Diamond Research is or what their motivation was for writing this report, but I really don't have any knowledge to the contrary of any of their points. The report was published early 2016. I don't know why they discontinued their SPIDER system sales if they had nothing approved to replace it; that sounds like either a poor business decision based on ridiculous levels of overconfidence, or they knew it had some critical flaw which would bite them in the ass if they kept selling it. Just my guess on that.

But I would say that anyone with a great level of optimism for Senhance's future might want to look at the device's track record. Maybe Americans are more willing to have extra holes poked in their abdomens than Europeans. That's why they didn't sell in Europe. They are now in what, seven hospitals? CE mark seven years ago and already in seven hospitals. Wow. Awesome. I better invest! Here's my three bucks. I'll take one share of TRXC please, so I can retire when they sell their tenth system. In three more years.